Scarica l'app Stockscreener
0.8391
15.78%
-0.1572
Pre-mercato:
.77
-0.0691
-8.24%
Precedente Chiudi:
$0.9963
Aprire:
$0.8704
Volume 24 ore:
769.49K
Relative Volume:
1.23
Capitalizzazione di mercato:
$34.50M
Reddito:
$1.88M
Utile/perdita netta:
$-8.48M
Rapporto P/E:
-4.4609
EPS:
-0.1881
Flusso di cassa netto:
$-19.13M
1 W Prestazione:
-3.55%
1M Prestazione:
-36.91%
6M Prestazione:
-33.93%
1 anno Prestazione:
-58.25%
Intervallo 1D:
$0.78
$0.875
Intervallo di 1 settimana:
$0.73
$1.35
Portata 52W:
$0.73
$2.44
Beyondspring Inc Stock (BYSI) Company Profile
Nome
Beyondspring Inc
Settore
Industria
Telefono
646-528-4184
Indirizzo
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
0.8391 | 30.51M | 1.88M | -8.48M | -19.13M | -0.1881 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-12-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-12-02 | Downgrade | Jefferies | Buy → Hold |
| 2021-12-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2021-12-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-09-09 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-04-05 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2021-01-11 | Iniziato | BofA Securities | Buy |
| 2020-12-29 | Iniziato | Evercore ISI | Outperform |
| 2020-02-07 | Iniziato | Jefferies | Buy |
| 2020-01-10 | Iniziato | Nomura | Buy |
| 2019-12-03 | Iniziato | William Blair | Outperform |
| 2019-07-10 | Reiterato | H.C. Wainwright | Buy |
| 2019-04-30 | Downgrade | Maxim Group | Buy → Hold |
| 2018-10-25 | Reiterato | Maxim Group | Buy |
Mostra tutto
Beyondspring Inc Borsa (BYSI) Ultime notizie
BeyondSpring (BYSI) Q2 Results Highlight Challenges Amid High Price-to-Sales Valuation - GuruFocus
BeyondSpring Cash Drops to $6.4M, Escalating Going-Concern Risk - Minichart
BeyondSpring Cash Drops to $6.5M as DUBLIN-4 Trial Funding Looms - Minichart
BeyondSpring Q2 loss narrows to $849k; EPS improves to $(0.02) - scanx.trade
BeyondSpring Inc. (BYSI) founders disclose 5.29M shares each in 13G/A - Stock Titan
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
BYSI: Net loss increased to $5.7M in Q2 2026, with urgent need for new funding amid ongoing R&D - TradingView
BeyondSpring (BYSI) posts deeper H1 2026 loss and flags going concern risk - Stock Titan
BeyondSpring Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BeyondSpring Posts $5.7 Million Second-Quarter Net Loss - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Beyondspring Inc (BYSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vascular Disrupting Agents Market - Future Market Insights
Beyondspring Inc (BYSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss Amid Pipeline ProgressShort-Term Outlook - dars.gov.et
Beyondspring Inc (BYSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BYSI|Beyondspring Inc|Price:0.839|Chg%:-0.157 - TradingKey
Beyondspring Inc (BYSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Beyondspring Inc (BYSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beyondspring Inc (BYSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Beyondspring Inc (BYSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Beyondspring Inc (BYSI) Income Statement - TradingKey
BYSI|Beyondspring Inc|Price:1.150|Chg%:+0.030 - TradingKey
Beyondspring Inc (BYSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
BYSI|Beyondspring Inc|Price:0.775|Chg%:+0.033 - TradingKey
BeyondSpring, Inc. Revenue Breakdown – NASDAQ:BYSI - TradingView
BYSI|Beyondspring Inc|Price:1.120|Chg%:+0.040 - TradingKey
Beyondspring Inc (BYSI) Institutional Confidence - TradingKey
Na (nl) Li Net Worth (2026) - GuruFocus
Min Qiu Net Worth (2026) - GuruFocus
BeyondSpring (BYSI) Q1 2026 Earnings: EPS Loss of -$0.05 Amid No Revenue and Stock DeclineGuidance vs Actual - DonanımHaber
Form 4 BeyondSpring Inc For: 6 July By Investing.com - Investing.com Nigeria
BeyondSpring (BYSI) CEO Qiu Min reports direct holding of 2,498 Ordinary Shares - Stock Titan
BeyondSpring (BYSI) director receives 100,000 stock options grant - Stock Titan
BeyondSpring (BYSI) CFO Li Na submits initial Form 3 ownership filing - Stock Titan
BYSI Q1 2026 Earnings: Narrowing Net Loss Reinforces Strategic FocusConsensus Miss Rate - dars.gov.et
BeyondSpring Inc. (BYSI) Edges Higher with Modest Gains, Testing Key Resistance LevelsTRIN Signal - dars.gov.et
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Narrowing Per‑Share Loss Amid Ongoing Pipeline FocusBalance Sheet Strength - dars.gov.et
BeyondSpring (BYSI) finalizes CEO Min Qiu salary, bonus and option grant - Stock Titan
BeyondSpring Inc.(NasdaqCM: BYSI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
BeyondSpring Inc.(NasdaqCM:BYSI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
BYSI Q1 2026 Earnings: Narrowed Loss as Pipeline AdvancesEarnings Preview - dars.gov.et
BYSI Q1 2026 Earnings: Narrowing Losses Amid Pipeline Progress, Stock Gains 5.6%Pre-Earnings Drift - dars.gov.et
Price to book forward of BeyondSpring, Inc. – NASDAQ:BYSI - TradingView
Price to sales forward of BeyondSpring, Inc. – NASDAQ:BYSI - TradingView
Enterprise value to revenue forward of BeyondSpring, Inc. – NASDAQ:BYSI - TradingView
BeyondSpring Inc. Actuals & Estimates (NASDAQ:BYSI) - TradingView
BYSI Q1 2026 Earnings: Loss Per Share Narrows as Clinical Pipeline AdvancesEPS Growth Report - dars.gov.et
BeyondSpring Inc. (BYSI) Slips 2.48%: Stock Tests Key Support at $1.49TPO Profile - dars.gov.et
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Narrowing Losses Amid Strategic Clinical ProgressGuidance Update - dars.gov.et
Beyondspring Inc Azioni (BYSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):